INITIAL COSTS OF TREATMENT AMONG STAGE IV PROSTATE CANCER (PCA) CHEMOTHERAPY PATIENTS IN SEER-MEDICARE

被引：0
|
作者：
Onukwugha, E.
Mullins, C. D. [1 ]
Seal, B. [2 ]
Hussain, A. [3 ]
机构：
[1] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA
[2] Sanofi Aventis Pharmaceut, Bridgewater, NJ USA
[3] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)72132-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A31 / A31
页数：1
相关论文
共 50 条
  • [31] Effects of initial treatment on survival among elderly AML patients: Findings from the SEER-medicare database.
    Menzin, Joseph
    Boulanger, Luke
    Karsten, Verena
    Cahill, Ann L.
    Earle, Craig E.
    BLOOD, 2006, 108 (11) : 558A - 558A
  • [32] Thromboembolic Events Among Older Ovarian Cancer Patients: A SEER-Medicare Analysis
    Shantakumar, Sumitra
    Frost, Alexandra C.
    Li, Li
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 410 - 410
  • [33] Costs of breast cancer recurrence after initial treatment for high risk early breast cancer using SEER-Medicare linked data
    Vitko, Alexandra S.
    Martin, Pamela A.
    Zhang, Sheng
    Johnston, Adam F.
    Ohsfeldt, Robert L.
    Zheng, Shen
    Liepa, Astra M.
    CANCER RESEARCH, 2023, 83 (05)
  • [34] Bone metastasis (BM) based on SEER registry versus Medicare claims among metastatic prostate cancer (PCa) patients (pts) in SEER-Medicare.
    Onukwugha, Ebere
    Mullins, C. Daniel
    Yong, Candice
    McNally, Diane L.
    Seal, Brian S.
    Hussain, Arif
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] Excess lifetime costs associated with colorectal cancer among elderly Medicare beneficiaries: Evidence from SEER-Medicare data
    Lang, K.
    Lines, L. M.
    Lee, D. W.
    Korn, J. R.
    Vanness, D. J.
    Earle, C. C.
    Menzin, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] Trends in Use of Postprostatectomy Therapies for Prostate Cancer: A SEER-Medicare Analysis
    Sheets, N. C.
    Hendrix, L. H.
    Allen, I. M.
    Chen, R. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S544 - S544
  • [37] Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC
    Shah, Shweta
    Blanchette, Christopher M.
    Coyle, Joseph C.
    Kowalkowski, Marc
    Arthur, Susan T.
    Howden, Reuben
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (09) : 861 - 868
  • [38] Outcomes and Utilization of Adjuvant Chemotherapy for Stage II Colon Cancer in the Oxaliplatin Period A SEER-Medicare Analysis
    Jiao, Xiayu
    Hay, Joel W.
    Sadeghi, Sarmad
    Barzi, Afsaneh
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (06): : 428 - 434
  • [39] Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation
    Beebe-Dimmer, Jennifer L.
    Ruterbusch, Julie J.
    Cooney, Kathleen A.
    Bolton, Adam
    Schwartz, Kendra
    Schwartz, Ann G.
    Heath, Elisabeth
    CANCER MEDICINE, 2019, 8 (06): : 3325 - 3335
  • [40] Measuring complications of cancer treatment using the SEER-Medicare data
    Potosky, AL
    Warren, JL
    Riedel, ER
    Klabunde, CN
    Earle, CC
    Begg, CB
    MEDICAL CARE, 2002, 40 (08) : 62 - 68
12345